🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 16 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
14/03/2014 22,89 23,38 22,23 23,02 -0,17% 5,02% 1.520.800
13/03/2014 25,02 25,35 22,16 23,06 -8,35% 12,75% 2.398.700
12/03/2014 25,07 25,93 24,02 25,16 -0,44% 7,61% 1.097.300
11/03/2014 26,75 27,01 25,01 25,27 -4,89% 7,48% 1.733.300
10/03/2014 24,54 26,82 23,84 26,57 +7,66% 12,14% 1.837.400
07/03/2014 25,61 25,99 22,53 24,68 -2,41% 13,51% 3.159.800
06/03/2014 27,06 27,63 24,50 25,29 -3,88% 11,57% 2.761.400
05/03/2014 24,06 27,24 23,95 26,31 +24,46% 13,67% 7.688.200
04/03/2014 20,37 21,50 20,01 21,14 +5,28% 7,31% 983.400
03/03/2014 19,90 20,90 19,44 20,08 +3,29% 7,34% 1.484.700
28/02/2014 20,01 20,72 18,50 19,44 -6,94% 11,09% 1.912.400
27/02/2014 22,02 22,27 20,50 20,89 -4,79% 8,04% 1.161.500
26/02/2014 21,15 22,25 21,00 21,94 +3,34% 5,91% 802.700
25/02/2014 22,47 22,47 20,56 21,23 -5,22% 8,50% 1.378.000
24/02/2014 22,63 23,14 22,02 22,40 -0,22% 4,95% 1.197.400
21/02/2014 22,68 23,03 22,18 22,45 +2,51% 3,75% 1.739.700
20/02/2014 21,05 22,19 20,86 21,90 +3,84% 6,32% 1.601.400
19/02/2014 19,68 21,74 19,64 21,09 +11,29% 10,67% 5.232.900
18/02/2014 19,09 19,50 18,80 18,95 -0,21% 3,67% 561.000
14/02/2014 19,79 20,00 18,50 18,99 -3,80% 7,58% 839.300
13/02/2014 18,82 19,96 18,50 19,74 +3,08% 7,76% 1.232.100
12/02/2014 18,92 19,17 17,85 19,15 +1,70% 6,98% 1.339.600
11/02/2014 18,26 19,08 17,90 18,83 +4,67% 6,46% 2.030.500
10/02/2014 17,50 18,00 16,91 17,99 +4,29% 6,23% 1.366.200
07/02/2014 15,74 17,38 15,43 17,25 +18,64% 12,39% 3.346.100
06/02/2014 14,46 15,54 14,23 14,54 +0,55% 9,05% 689.500
05/02/2014 15,00 15,00 13,91 14,46 -0,96% 7,27% 750.400
04/02/2014 15,31 15,54 14,60 14,60 -3,12% 6,14% 734.500
03/02/2014 15,24 15,41 14,51 15,07 -1,76% 5,91% 982.500
31/01/2014 15,01 15,72 14,77 15,34 +0,26% 6,33% 1.411.100